The Milan System SUMP Category: 5-Year Diagnostic Performance
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00064203%3A_____%2F25%3A10497821" target="_blank" >RIV/00064203:_____/25:10497821 - isvavai.cz</a>
Alternative codes found
RIV/00216208:11110/25:10497821
Result on the web
<a href="https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=ha6WhTkC23" target="_blank" >https://verso.is.cuni.cz/pub/verso.fpl?fname=obd_publikace_handle&handle=ha6WhTkC23</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1002/dc.25482" target="_blank" >10.1002/dc.25482</a>
Alternative languages
Result language
angličtina
Original language name
The Milan System SUMP Category: 5-Year Diagnostic Performance
Original language description
BACKGROUND: Salivary gland neoplasms are heterogeneous, with wide cytomorphological overlap. Neoplasms categorized in the Milan System for Reporting Salivary Gland Cytopathology (MSRSGC) as salivary gland neoplasms of uncertain malignant potential (SUMP) reflect this diagnostic challenge. METHODS: All salivary gland fine-needle aspirations (SG-FNA) diagnosed at Fimlab Laboratories over a 5-year period (January 1, 2018-December 31, 2022) that were classified as SUMP were included. Follow-ups were reviewed until May 31, 2024. The SUMP cases were classified into cytomorphological subtypes. The risk of malignancy (ROM), risk of neoplasm, and median timelines of the pathology laboratory workflow and patient management were calculated. In addition, separate analyses of the impact of age and sex were performed. RESULTS: A total of 1157 SG-FNAs were diagnosed over a 5-year period. Of these, 100 SG-FNAs from 52 females and 33 males were classified as SUMP. A total of 69 (69.0%) SUMP cases underwent histological verification. The ROM was 23.2% for all surgical follow-ups, 35.0% for the oncocytic/oncocytoid subtype, and 18.4% for the basaloid subtype. For the male and female groups, the ROMs were 26.9% and 16.2% for all surgical follow-ups, 40.0% and 14.3% for the oncocytic/oncocytoid subtype, and 18.8% and 16.7% for the basaloid subtype, respectively. CONCLUSIONS: The 5-year analysis of SUMP category performance showed a lower ROM in our practice than the MSRSGC reference value. The oncocytic/oncocytoid subtype presented a higher ROM than the basaloid subtype. The ROMs were highest in the male population and in the age group of 30-69 years.
Czech name
—
Czech description
—
Classification
Type
J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database
CEP classification
—
OECD FORD branch
30206 - Otorhinolaryngology
Result continuities
Project
—
Continuities
I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace
Others
Publication year
2025
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů
Data specific for result type
Name of the periodical
Diagnostic Cytopathology
ISSN
8755-1039
e-ISSN
1097-0339
Volume of the periodical
53
Issue of the periodical within the volume
8
Country of publishing house
US - UNITED STATES
Number of pages
12
Pages from-to
370-381
UT code for WoS article
001481721900001
EID of the result in the Scopus database
2-s2.0-105004348733